Israel: Beyond the Risk, Opportunities Beckon

When you think of Israel, you probably think of conflict. But it has a strong economy and growing companies if you're willing to be a bit daring. More 

Pharma’s Q2 Earnings Lesson: The Big Picture Looks Good

The promising signs coming out of pharma this quarter doesn't mean you can just pick a stock out of a hat -- but it does mean a few are worth picking. More 

Novartis Wins Approval for Breast Cancer Drug

The FDA has granted approval for Novartis' drug Afinitor to be used as a treatment for breast cancer after it showed promise in clinical trials. More 

Retail Results Spoil the Day — Monday’s IP Market Recap

A disappointing retail report and mixed results for Citigroup's second quarter weighed on markets Monday, though M&A news sparked life into pharma. More 

Nestle’s is More Than Just Chocolate and Candy

Nestlé together with its subsidiaries, provides nutrition, health, and wellness products worldwide, and is an international dividend achiever. More 

Medidata Solutions a Strong Buy in Cloud Computing

Medidata Solutions is a fast-growing cloud services provider to the health care industry that is poised for even better growth and is a buying opportunity More 

Nestle: A Global Dividend Powerhouse

Nestle is a world wide brand name that produces products, earnings, and dividends at a remarkable rate every year. Nestle is a great portfolio buy. More